Davinder Kaur

Davinder Kaur

Auto-generated profile, based on publicly available information

Davinder Kaur

Department of Respiratory Sciences Institute for Lung Health NIHR Biomedical Research Centre University of Leicester Leicester LE1 7RH UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2020 in Science Translational Medicine
Verified
Journal Article
Open access
RPRudi Prihandoko
Rudi Prihandoko
DKDavinder Kaur
Davinder Kaur
CWCoen H. Wiegman
Coen H. Wiegman
EAElisa Alvarez-Curto
Elisa Alvarez-Curto
CDChantal Donovan
Chantal Donovan
ATAndrew B. Tobin
Andrew B. Tobin
FFA4 receptor agonism corrects dysfunctional lung responses and inflammation in models and is a potential target for inflammatory lung disease.

1 January 2021 in Clinical & Translational Immunology
Verified
Journal Article
Open access
PDF file
DKDavinder Kaur
Davinder Kaur
LCLatifa Chachi
Latifa Chachi
EGEdith Gomez
Edith Gomez
NSNicolas Sylvius
Nicolas Sylvius
CBChristopher E Brightling
Christopher E Brightling
Objective: In asthma, genome‐wide association studies have shown that interleukin‐18 (IL‐18) receptor 1 gene (IL‐18R1) and sputum IL‐18 are increased during exacerbations. However, the role of the IL‐18 axis in bronchial epithelial function is unclear. To investigate IL‐18, IL‐18 binding protein (BP) and IL‐18R expression in bronchial biopsies and sputum samples from patients with asthma, and to determine its functional role using in vitro bronchial epithelial cells.Methods: The expression of IL‐18, IL‐18BP and IL‐18Rα was examined in subjects with asthma and healthy controls in bronchial biopsies by immunohistochemistry and IL‐18 and IL‐18BP release in sputum. In epithelial cells, the mRNA and protein expression of IL‐18, IL‐18BP, IL‐18Rα and IL‐18Rβ was assessed by qPCR, flow cytometry, Western blotting and immunofluorescence respectively. IL‐18 function in epithelial cells was examined by intracellular calcium, wound repair, synthetic activation and epithelial differentiation changes.Results: In biopsies from subjects with asthma, the IL‐18 expression was not different in the lamina propria compared with controls but was decreased in the epithelium. In contrast, the IL‐18BP was decreased in the lamina propria in asthma and was absent in the bronchial epithelium. IL‐18 was released in sputum with IL‐18BP elevated in patients with asthma. The IL‐18Rα expression was not different between health and disease. In vitro, IL‐18‐stimulated bronchial epithelial cells increased intracellular calcium, wound repair, metabolic activity, morphological changes and epithelial cellular differentiation.Conclusion: In asthma, the dynamic interaction between IL‐18, its cognate receptor and natural inhibitor is complex, with differences between airway compartments. Upregulation of IL‐18 can promote epithelial activation and cellular differentiation.

9 June 2020 in Allergy
Verified
Journal Article
Open access
PDF file
DKDavinder Kaur
Davinder Kaur
LCLatifa Chachi
Latifa Chachi
EGEdith Gomez
Edith Gomez
NSNicolas Sylvius
Nicolas Sylvius
SSShailendra R. Singh
Shailendra R. Singh
CBChristopher E. Brightling
Christopher E. Brightling
Background: The airway epithelium plays an important role in wound repair, host defense and is involved in the immunopathogenesis of asthma. Genome wide association studies have described associations between ST2/Interleukin (IL)‐33 genes in asthma, but its role in bronchial epithelium is unclear.Methods: ST2 expression was examined in subjects with asthma and healthy controls in bronchial epithelium from biopsies (n = 27 versus n = 9) and brushings (n = 34 versus n = 20) by immunohistochemistry and RNA‐Seq. In human primary bronchial epithelial cells ST2 mRNA and protein expression were assessed by qPCR, flow cytometry, Western blotting, and immunofluorescence. IL‐33 function in epithelial cells was examined by intracellular calcium measurements, wound healing assays, and synthetic activation by gene array and ELISA.Results: Bronchial epithelial ST2 protein expression was significantly decreased in biopsies in subjects with asthma compared to healthy controls (P = .039). IL1RL1 gene expression in bronchial brushes was not different between health and disease. In vitro primary bronchial epithelial cells expressed ST2 and IL‐33 stimulation led to an increase in intracellular calcium, altered gene expression, but had no effect upon wound repair. Epithelial cells released sST2 spontaneously, which was reduced following stimulation with TNFα or poly‐IC. Stimulation by TNFα or poly‐IC did not affect the total ST2 expression by epithelial cell whereas surface ST2 decreased in response to TNFα, but not poly‐IC.Conclusion: In asthma, bronchial epithelium protein expression of ST2 is decreased. Our in vitro findings suggest that this decrease might be a consequence of the pro‐inflammatory environment in asthma or in response to viral infection.